SL1002, Normal Saline — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-30 in 2mo
ESTIMATED |
READOUT
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis K
Phase 3 · Osteoarthritis Knee Pain |
Saol Therapeutics Inc | SL1002, Normal Saline |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|